Davidson Kahn Capital Management’s eXoZymes EXOZ Stock Holding History
Bought
Maintained
Sold
Other funds holding EXOZ
Davidson Kahn Capital Management's EXOZ Position: Q3 2026 in Review
Davidson Kahn Capital Management reduced its eXoZymes (EXOZ) stake by 28% in Q3 2026, selling an estimated $43.4K and leaving 18,000 shares worth $105K. The position accounts for 0.04% of the portfolio, ranked #67.
Davidson Kahn Capital Management first reported a position in EXOZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $211K in Q2 2026. 9 funds tracked by Wall St. Rank hold EXOZ as of Q3 2026.
- Davidson Kahn Capital Management held 18,000 shares of eXoZymes worth $105K as of Q3 2026.
- Davidson Kahn Capital Management sold 7,000 eXoZymes shares in Q3 2026, an estimated $43.4K.
- eXoZymes made up 0.04% of Davidson Kahn Capital Management's portfolio in Q3 2026, its #67 holding.
- Davidson Kahn Capital Management first reported a position in eXoZymes in Q2 2026 and has held it in 2 quarters since.
- Davidson Kahn Capital Management's eXoZymes position peaked at $211K in Q2 2026.
- 9 funds tracked by Wall St. Rank held eXoZymes as of Q3 2026.
Based on Davidson Kahn Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.